Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.47
+0.09 (1.67%)
At close: Jan 7, 2026, 4:00 PM EST
5.47
0.00 (0.00%)
After-hours: Jan 7, 2026, 4:10 PM EST
Generation Bio Co. Employees
Generation Bio Co. had 115 employees as of December 31, 2024. The number of employees decreased by 59 or -33.91% compared to the previous year.
Employees
115
Change (1Y)
-59
Growth (1Y)
-33.91%
Revenue / Employee
$132,783
Profits / Employee
-$544,583
Market Cap
36.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 115 | -59 | -33.91% |
| Dec 31, 2023 | 174 | 24 | 16.00% |
| Dec 31, 2022 | 150 | 0 | - |
| Dec 31, 2021 | 150 | 50 | 50.00% |
| Dec 31, 2020 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GBIO News
- 23 days ago - XOMA Royalty Enters into Agreement to Acquire Generation Bio - GlobeNewsWire
- 2 months ago - Generation Bio Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Generation Bio Announces CEO Transition - GlobeNewsWire
- 5 months ago - Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Generation Bio Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 6 months ago - Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 months ago - Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 8 months ago - Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - GlobeNewsWire